Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management.
about
The HER2 Receptor in Breast Cancer: Pathophysiology, Clinical Use, and New Advances in TherapyHeart failure in chemotherapy-related cardiomyopathy: Can exercise make a difference?Vascular Complications of Cancer ChemotherapyMultimodality Imaging in CardiooncologyEvaluation and management of patients with heart disease and cancer: cardio-oncologyAngiogenesis inhibitor bevacizumab increases the risk of ischemic heart disease associated with chemotherapy: a meta-analysisBNP predicts chemotherapy-related cardiotoxicity and death: comparison with gated equilibrium radionuclide ventriculographyp53 initiates apoptosis by transcriptionally targeting the antiapoptotic protein ARCBusulphan-cyclophosphamide cause endothelial injury, remodeling of resistance arteries and enhanced expression of endothelial nitric oxide synthaseMeta-analysis of cardiovascular toxicity risks in cancer patients on selected targeted agents.Management of chemotherapy induced cardiomyopathy.Cardio-oncology: a new medical issue.In situ imaging in C. elegans reveals developmental regulation of microtubule dynamicsIschemic Heart Disease: Special Considerations in Cardio-Oncology.Aortic stiffness increases upon receipt of anthracycline chemotherapyCardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological preventionTwo-dimensional strain echocardiography for detection of cardiotoxicity in breast cancer patients undergoing chemotherapy.Cardiomyocyte death in doxorubicin-induced cardiotoxicityCardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trialsDexrazoxane protects the heart from acute doxorubicin-induced QT prolongation: a key role for I(Ks).Role of cardiac magnetic resonance in the evaluation of dilated cardiomyopathy: diagnostic contribution and prognostic significance.Micromolded gelatin hydrogels for extended culture of engineered cardiac tissues.Time course of changes in oxidative stress and stress-induced proteins in cardiomyocytes exposed to doxorubicin and prevention by vitamin C.Cardiotoxicity following cyclophosphamidetherapy: a case reportNuclear imaging in detection and monitoring of cardiotoxicity.Epicardium Formation as a Sensor in Toxicology.Chemotherapy-induced cardiotoxicity.Management of mucopolysaccharidosis type IH (Hurler's syndrome) presenting in infancy with severe dilated cardiomyopathy: a single institution's experience.Protective effect of guggulsterone against cardiomyocyte injury induced by doxorubicin in vitroWeekly doxorubicin increases coronary arteriolar wall and adventitial thickness.Impact of cardiac computed tomographic angiography findings on planning of cancer therapy in patients with concomitant structural heart disease.Development and Validation of Endovascular Chemotherapy Filter Device for Removing High-Dose Doxorubicin: Preclinical StudyCardiovascular event-free survival after adjuvant radiation therapy in breast cancer patients stratified by cardiovascular risk.Angiotensin Converting Enzyme Inhibitors (ACEI) and doxorubicin pharmacokinetics in women receiving adjuvant breast cancer treatmentThe utility of cardiac stress testing for detection of cardiovascular disease in breast cancer survivors: a systematic review.Exercise Intervention for Cancer Survivors with Heart Failure: Two Case Reports.Identification of novel biomarkers for doxorubicin-induced toxicity in human cardiomyocytes derived from pluripotent stem cells.Senescence marker protein 30 has a cardio-protective role in doxorubicin-induced cardiac dysfunction.Impairments that influence physical function among survivors of childhood cancerRituximab-induced Takotsubo syndrome: more cardiotoxic than it appears?
P2860
Q21284978-4E3D2DD6-A5F1-445C-9A53-94F8CCE4E6C7Q26740352-BF6DB870-3EC9-4B93-A4A1-9A5B5CA775F5Q26766269-B2AA29B8-8F7B-4E54-B466-898FEEE8011BQ26795452-E9B0B7A9-7399-4AB4-815E-3C4CF6284611Q26998273-2EAB713B-91E3-4047-BB7E-8F641A45A15AQ28534015-0B9E72D2-1885-4142-B072-A7EE0A36386DQ28538548-9753C9BB-2184-4E74-944D-2A5175933CA0Q28569720-B6E0DB92-7CC2-4D13-B769-ECFE24DD10E9Q28732371-1F2281AA-EC9C-42C8-9484-11070D44B959Q30249335-02121A34-C88F-4802-BCC8-BC9B1F83374FQ30461441-C7706D32-9EEE-4E09-82FB-3F2C28070560Q30471284-745CDA06-2684-4FBF-A68B-1AF9F5F3352BQ30581020-06E7C883-D618-4B81-A673-161145B2476CQ33441165-A903A483-0F55-46F4-995A-5B807046D6F8Q33561937-F5B897BF-5331-4D33-8BF5-8FBACE69E246Q33574045-AD9D9FC2-78F8-47EA-989A-42496E3CD04AQ33593674-952DBDC5-FED2-43E3-A300-3605F676FEE8Q33604134-5B8F1166-4FDD-4C60-9EB7-136A265D949BQ33619867-5896ED5E-1533-4800-8ED1-B30498DCC3DDQ33661049-BD5FC5C8-8E24-4845-B217-A9CE1BD061B9Q33711320-23D20CDE-DA73-48D8-94E8-A97C17039FD9Q33753038-180569EB-8132-437A-BC0E-311EB7353001Q33873796-052B0F7F-B7E2-46F1-99F5-34470EEE8019Q33930737-8FEDAC6E-E28A-495E-A8FA-DDBF2CE9F106Q33942611-1A830EBC-AE28-4D3E-BCBA-1D78BF2E458DQ34181978-08CBA2C6-F888-4568-BB71-FEEFA5E3AFA9Q34258080-2A4A3B94-F706-4A77-83CF-91586007B84FQ34311268-7143F0FC-8561-4E46-94C1-AAB252D39526Q34392758-469DE48C-8064-4F92-A5C6-D64B9F84516BQ34600610-D4F36567-F17F-4549-A933-32129190948AQ34928832-7DCDB3ED-CABF-41A9-8170-9441C134D1ACQ34981443-A744FB47-E487-42B3-A497-06C62087283AQ34998564-B0BC31B0-C3AB-4EC0-9509-8158E0B7E10AQ35024342-43B7E2EA-7D41-42CC-8978-79C6362DE8F3Q35043809-B7EC53F3-15DF-4FA7-96A9-EE824BCE9848Q35062392-BFAC8CD1-ADB7-40C0-9A72-E954D91511CCQ35078142-A5ED1D68-289F-4420-AB9D-E8354C3717B8Q35082301-64E0E32A-AB82-41D1-A9AA-3A32059E3CDAQ35082766-AABCED6B-7C3E-4DF3-B4FD-C971A9F478B5Q35204124-880AF6E9-83D8-405D-8D79-CB8305BFF6D2
P2860
Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management.
@ast
Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management.
@en
type
label
Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management.
@ast
Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management.
@en
prefLabel
Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management.
@ast
Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management.
@en
P2093
P1433
P1476
Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management.
@en
P2093
Alireza Atef Zafarmand
Ann T Tong
Christopher Champion
Daniel J Lenihan
Edward T H Yeh
Harry Gibbs
Jean-Bernard Durand
Joseph Swafford
Michael S Ewer
S Wamique Yusuf
P304
P356
10.1161/01.CIR.0000133187.74800.B9
P407
P577
2004-06-01T00:00:00Z